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OBJECTIVE — We have already reported that A1C is elevated because of iron deﬁciency in
late pregnancy among nondiabetic pregnant women. This report examined whether the same
phenomenon is observed in pregnant women with diabetes.
RESEARCHDESIGNANDMETHODS — Thislongitudinalstudywasconductedin17
pregnant women with diabetes (20–35 weeks of pregnancy). A1C, serum glycated albumin,
erythrocyte indexes, and iron metabolism indexes were measured.
RESULTS — A1C levels were signiﬁcantly increased in late pregnancy, whereas serum gly-
cated albumin showed no signiﬁcant changes. Glycated albumin/A1C ratio, mean corpuscular
hemoglobin,serumtransferrinsaturation,andserumferritinweresigniﬁcantlydecreasedinlate
pregnancy. Serum transferrin saturation showed a signiﬁcant positive correlation with glycated
albumin/A1C ratio.
CONCLUSIONS — A1C levels, but not serum glycated albumin levels, are elevated in late
pregnancy because of iron deﬁciency in diabetic women. Serum glycated albumin may offer an
adequate marker for glycemic control during pregnancy.
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I
n pregnant women with diabetes,
namely women with gestational diabe-
tes, type 2 diabetes, or type 1 diabetes,
tight glycemic control during pregnancy is
essential to reduce the risk of intrauterine
fetal death, fetal growth abnormalities, and
maternalcomplications(1).Inpatientswith
diabetes, several glycated proteins can be
used as markers to evaluate glycemic con-
trol. Among them, A1C is currently in wide
useasthestandardmarkerforclinicalman-
agement of diabetes (2).
A1C is inﬂuenced not only by blood
glucose levels, but also by conditions that
affect erythrocyte survival (3). Although
in patients with iron deﬁciency anemia,
A1C is known to be elevated (4), we re-
cently found that A1C levels are also ele-
vated in iron deﬁciency states without
anemia (5). Furthermore, a study in non-
diabetic pregnant women on correlations
between glycemic control markers (A1C
andserumglycatedalbumin)andironde-
ﬁciency status reported that in late preg-
nancy,A1Clevelswereincreasedbecause
of iron deﬁciency, but serum glycated al-
bumin levels were not inﬂuenced by such
conditions (6).
Accordingly, we believed that a simi-
lar study on glycemic control markers in
pregnant women with diabetes would be
clinically important. We therefore con-
ducted this study in pregnant women
with diabetes.
RESEARCH DESIGN AND
METHODS— Thislongitudinalstudy
was conducted in 17 Japanese pregnant
womenwithdiabeteswhowereevaluated
between January 2007 and August 2009
at Aizenbashi Hospital or Osaka Medical
Center and Research Institute for Mater-
nal and Child Health. Mean age of the
womenwas30.54.1years.Categoryof
diabetes for the study patients was gesta-
tional diabetes in 6, type 2 diabetes in 4,
and type 1 diabetes in 7. Diabetes treat-
ment was dietary therapy alone in 4 and
insulin therapy in 13. During the obser-
vation period, iron and vitamin supple-
mentswerenotpermitted.Thepregnancy
period was divided into four terms of 4
weeks each, starting at gestational week
20: Term I, 20–23 weeks; term II, 24–27
weeks; term III, 28–31 weeks; and term
IV, 32–35 weeks. In each term, A1C, se-
rum glycated albumin, erythrocyte (red
blood cell) count, hematocrit, hemoglo-
bin mean corpuscular hemoglobin, se-
rum transferrin saturation, and serum
ferritin were measured. A1C was mea-
sured by high-performance liquid chro-
matography (ADAMS-A1C HA-8160;
Arkray,Kyoto,Japan)(7)withcalibration
using Japan Diabetes Society (JDS) Lot 2
(8). Serum glycated albumin was de-
termined by enzymatic methods using
albumin-speciﬁc protease, ketoamine
oxidase, and albumin assay reagent (Lu-
cica GA-L; Asahi Kasei Pharma, Tokyo,
Japan) (9). Blood cell counts, hematocrit,
hemoglobin, and mean corpuscular he-
moglobin were measured using an auto-
mated hematology system. Serum ferritin
concentrations were measured by chemi-
luminescent immunoassay. Serum trans-
ferrin saturation was calculated by
dividing serum iron by total iron binding
capacity determined by the calorimetric
method.
RESULTS— Figure 1 shows A1C lev-
els and serum glycated albumin levels in
the four terms during pregnancy. A1C
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with a signiﬁcant increase in late preg-
nancy (term I, 5.4  0.7%; term II, 5.4 
0.8%; term III, 5.6  0.7%; term IV,
5.7  0.6%; P  0.05 for each of term I
versus IV and term II versus IV; P  0.01
for term II versus III). By contrast, serum
glycated albumin levels did not change
signiﬁcantly during the four terms. Gly-
cated albumin/A1C ratio decreased as
pregnancy progressed, with a signiﬁcant
decreaseinlatepregnancy(termI,2.91
0.47; term II, 2.90  0.36; term III,
2.78  0.36; term IV, 2.65  0.30; P 
0.05 for term I versus term III; P  0.01
foreachoftermIversusIV,termIIversus
III and term III versus IV; P  0.001 for
term II versus IV).
Red blood cell count did not change
during pregnancy, but mean corpuscular
hemoglobin in term IV was signiﬁcantly
decreased (term I, 29.9  1.8 pg; term II,
29.9  2.0 pg; term III, 29.6  2.3 pg;
termIV,28.72.7pg;P0.01forterm
I versus IV, P  0.001 for each of term II
versus IV and term III versus IV). Also,
serum transferrin saturation (term I,
22.8  9.7%; term II, 19.4  10.2%;
term III, 15.8  10.3%; term IV, 14.4 
9.6%; P  0.05 for each of term II versus
III and term II versus IV; P  0.01 for
term I versus II; P  0.001 for each of
termIversusIIIandtermIversusIV)and
log-ferritin (term I, 1.35  0.58; term II,
1.06  0.64; term III, 0.81  0.64; term
IV, 0.76  0.58; P  0.05 for term II
versus IV; P  0.01 for term II versus III;
P  0.001 for term I versus II, term I
versus III and term I versus IV) decreased
as pregnancy progressed, with a signiﬁ-
cant decrease in late pregnancy (Fig. 1).
Analysis of the correlation between
glycated albumin/A1C ratio and iron me-
tabolismindexesusingunivariateanalysis
showed that serum transferrin saturation
showed a signiﬁcant positive correlation
with glycated albumin/A1C ratio (R 
0.297, P  0.0214).
CONCLUSIONS— In normal preg-
nancy, A1C shows biphasic changes with a
nadir in mid-pregnancy (10,11). The de-
crease in A1C levels until mid-pregnancy is
thought to be due to a decline in blood glu-
cose levels from early to mid-pregnancy.
Conversely, Nielsen et al. (12) have re-
ported that A1C levels begins to decline
from early pregnancy and is further de-
creased in late pregnancy. In their study,
whether pregnant women had iron deﬁ-
ciency was not investigated.
In patients with gestational diabetes
during treatment or with a previous his-
tory of diabetes during pregnancy, some
discrepancies between A1C levels and
changesinbloodglucoselevelshavebeen
reported (13).
Given hemodilution seen in preg-
nancy, serum protein concentration de-
creases, and thus fructosamine levels can
be inﬂuenced during pregnancy. Serum
glycatedalbuminmeasuresglycatedalbu-
min as a ratio of serum albumin and is
therefore unaffected by the serum albu-
min concentration. During pregnancy,
glycated albumin levels have been re-
ported to decrease slightly from early to
mid-pregnancy (14). In our study, from
mid-pregnancy to late pregnancy, no sig-
niﬁcant change in serum glycated albu-
min levels was identiﬁed. Similar results
were also reported by Abe et al. (15).
Based on our ﬁndings, not only in
nondiabetic pregnant women, but also in
pregnant women with diabetes, it is im-
portant to keep in mind that iron deﬁ-
ciency and an increase in A1C levels can
occur in late pregnancy. By contrast, se-
rum glycated albumin levels are unaf-
fected by iron deﬁciency and thus may
offer an adequate marker for monitoring
glycemic control during pregnancy.
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